Interface Biologics Expands Scientific Advisory Board

Toronto, Canada, October 19, 2009 – For Immediate Release

Interface Biologics Inc. (IBI), a privately held developer of novel biomedical-polymers for use in implantable medical devices,…

Biomedical Polymer Is Proving to be a Powerful Infection Fighter that Protects Patients

Interface Biologics, Toronto, Ontario

Just about everyone on the planet will get a sliver of something in a finger at one…

Antimicrobial-Infused Polymer Demonstrates Backbone

Bob Michaels

Implants often rely on antimicrobial coatings to prevent infections. But the release of antibacterial agents via diffusion from a biomaterial’s surface may not be the most effective approach for…

Interface Biologics Appoints Arthur L. Rosenthal, Ph.D. to Board of Directors

Toronto, Canada, July 27, 2009 - For Immediate Release

Interface Biologics Inc. (IBI), a privately held developer of novel biomedical-polymers for…

Canadian biomedical engineering pioneer receives international award

Hamilton, ON - Countless individuals around the world are alive because of him. His 40 plus years of research have helped to make the use of life-saving devices…

Biomaterials maker puts devices to work inside the body

June 23, 2009 Biomaterials maker puts devices to work inside the body
By OMAR EL AKKAD
From Tuesday's Globe and Mail

For years, some…

Interface Biologics Announces Expansion of Senior Management Team

Toronto, Canada, May 19, 2009 - For Immediate Release

Interface Biologics Inc., a privately held developer of novel biomedical-polymers for use in implantable medical devices ,

Dr. Bradley Strauss presents Kinesyx Oligomer Coating on Stent at CRT 2009

Toronto, Canada, March 5, 2009 - FOR IMMEDIATE RELEASE

Interface Biologics Inc. announced that Bradley Strauss, M.D., Ph.D., FACC, presented data for…